The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Characteristics and outcomes of culture-negative versus culture-positive severe sepsis.
Open accessAbstract
Introduction: Culture-negative sepsis is a common but relatively understudied condition. The aim of this study was to compare the characteristics and outcomes of culture-negative versus culture-positive severe sepsis. Methods: This was a prospective observational cohort study of 1001 patients who were admitted to the medical intensive care unit (ICU) of a university hospital from 2004 to 2009 with severe sepsis. Patients with documented fungal, viral, and parasitic infections were excluded. Results: There were 415 culture-negative patients (41.5%) and 586 culture-positive patients (58.5%). Gram-positive bacteria were isolated in 257 patients, and gram-negative bacteria in 390 patients. Culture-negative patients were more often women and had fewer comorbidities, less tachycardia, higher blood pressure, lower procalcitonin levels, lower Acute Physiology and Chronic Health Evaluation II (median 25.0 (interquartile range 19.0 to 32.0) versus 27.0 (21.0 to 33.0), P = 0.001) and Sequential Organ Failure Assessment scores, less cardiovascular, central nervous system, and coagulation failures, and less need for vasoactive agents than culture-positive patients. The lungs were a more common site of infection, while urinary tract, soft tissue and skin infections, infective endocarditis and primary bacteremia were less common in culture-negative than in culture-positive patients. Culture-negative patients had a shorter duration of hospital stay (12 days (7.0 to 21.0) versus 15.0 (7.0 to27.0), P = 0.02) and lower ICU mortality than culture-positive patients. Hospital mortality was lower in the culture-negative group (35.9%) than in the culture-positive group (44.0%, P = 0.01), the culture-positive subgroup, which received early appropriate antibiotics (41.9%, P = 0.11), and the culture-positive subgroup, which did not (55.5%, P < 0.001). After adjusting for covariates, culture positivity was not independently associated with mortality on multivariable analysis. Conclusions: Significant differences between culture-negative and culture-positive sepsis are identified, with the former group having fewer comorbidities, milder severity of illness, shorter hospitalizations, and lower mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“approximately one-third of patients initially treated for possible sepsis end up having noninfectious diagnoses and culture-positive sepsis accounts for a minority of cases (only 24% in our study).”
From Trends in empiric broad-Spectrum antibiotic use for suspected community-onset Sepsis in US hospitals (2024) · cites this paper as [31]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,995
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Vincent, J.-L. (2009) · JAMA · doi:10.1001/jama.2009.1754 · Cited by 3,618
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2210-z · Cited by 3,321
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000117317.18092.e4 · Cited by 3,018
Sepsis in European intensive care units: Results of the SOAP study*
Vincent, J.-L., Sakr, Y., Sprung, C. L., Ranieri, V. M., Reinhart, K., Gerlach, H., Moreno, R., Carlet, J., Le Gall, J.-R., & Payen, D. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000194725.48928.3a · Cited by 2,836
The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study
Rangel-Frausto, M. S. (1995) · JAMA · doi:10.1001/jama.273.2.117 · Cited by 2,104
Dellinger, R. P. (2004) · Critical Care Medicine · Cited by 1,848
Russell, J. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmra043632 · Cited by 1,048
Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study
Alberti, C., Brun-Buisson, C., Burchardi, H., Martin, C., Goodman, S., Artigas, A., Sicignano, A., Palazzo, M., Moreno, R., Boulmé, R., et al. (2002) · Intensive Care Medicine · doi:10.1007/s00134-001-1143-z · Cited by 979
Calandra, T., & Cohen, J. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000168253.91200.83 · Cited by 839
Brun-Buisson, C. (1995) · JAMA · doi:10.1001/jama.1995.03530120060042 · Cited by 772
Paul, M., Shani, V., Muchtar, E., Kariv, G., Robenshtok, E., & Leibovici, L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00627-10 · Cited by 724
(2004) · Intensive Care Medicine · doi:10.1007/s00134-003-2121-4 · Cited by 638 · cited 4×
“The 1992 ACCP/SCCM Consensus Conference criteria that we and many other investigators used to define sepsis [11,17,18] - as well as subsequent adaptations - are based on a composite of clinical and laboratory data and will inevitably include a heterogeneous set of diagnoses, some of which are false positives and unrel…”
BackgroundResultInfluentialCurrent Epidemiology of Septic Shock: The CUB-Réa Network
Annane, D., Aegerter, P., Jars-Guincestre, M. C., & Guidet, B. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2201087 · Cited by 637
Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study
Blanco, J., Muriel-Bombín, A., Sagredo, V., Taboada, F., Gandía, F., Tamayo, L., Collado, J., García-Labattut, Á., Carriedo, D., Valledor, M., et al. (2008) · Critical Care · doi:10.1186/cc7157 · Cited by 520
Sepsis: definition, epidemiology, and diagnosis
Lever, A., & Mackenzie, I. (2007) · BMJ · doi:10.1136/bmj.39346.495880.ae · Cited by 510
Schuetz, P. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.318 · Cited by 386
Pyogenic Liver Abscess as Endemic Disease, Taiwan
Tsai, F.-C., Huang, Y.-T., Chang, L.-Y., & Wang, J.-T. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1410.071254 · Cited by 361
Viral Infection in Patients with Severe Pneumonia Requiring Intensive Care Unit Admission
Choi, S.-H., Hong, S.-B., Ko, G.-B., Lee, Y., Park, H. J., Park, S.-Y., Moon, S. M., Cho, O.-H., Park, K.-H., Chong, Y. P., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201112-2240oc · Cited by 353
Zahar, J.-R., Timsit, J.-F., Garrouste-Orgeas, M., Français, A., Vesim, A., Descorps-Declere, A., Dubois, Y., Souweine, B., Haouache, H., Goldgran-Toledano, D., et al. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31821b827c · Cited by 248
Martin, C. M., Priestap, F., Fisher, H., Fowler, R. A., Heyland, D. K., Keenan, S. P., Longo, C. J., Morrison, T., Bentley, D., & Antman, N. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819285f0 · Cited by 189
Heffner, A. C., Horton, J. M., Marchick, M. R., & Jones, A. E. (2010) · Clinical Infectious Diseases · doi:10.1086/650580 · Cited by 157
A multicenter trial to compare blood culture with polymerase chain reaction in severe human sepsis
Bloos, F., Hinder, F., Becker, K., Sachse, S., Dessap, A. M., Straube, E., Cattoir, V., Brun‐Buisson, C., Reinhart, K., Peters, G., et al. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1705-z · Cited by 143
Multiplex polymerase chain reaction detection enhancement of bacteremia and fungemia*
Louie, R. F., Tang, Z., Albertson, T. E., Cohen, S., Tran, N. K., & Kost, G. J. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31816f487c · Cited by 133
Thomsen, R. W., Hundborg, H. H., Lervang, H.-H., Johnsen, S. P., Schønheyder, H. C., & Sørensen, H. T. (2005) · Clinical Infectious Diseases · doi:10.1086/427699 · Cited by 130
Dark, P. M., Dean, P., & Warhurst, G. (2009) · Critical Care · doi:10.1186/cc7886 · Cited by 111
Antibiotic strategies in severe nosocomial sepsis: Why do we not de-escalate more often?*
Heenen, S., Jacobs, F., & Vincent, J. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182416ecf · Cited by 102
New method of classifying infections in critically ill patients*
Cohen, J., Cristofaro, P. A., Carlet, J. M., & Opal, S. M. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000129973.13104.2d · Cited by 97
Bacteremic sepsis in intensive care: Temporal trends in incidence, organ dysfunction, and prognosis
Hugonnet, S., Harbarth, S., Ferrière, K., Ricou, B., Suter, P. M., & Pittet, D. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000045026.81584.6f · Cited by 63
We should be measuring genomic bacterial load and virulence factors
Lisboa, T. C., WATERER, G. W., & Rello, J. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181f2453a · Cited by 34
The Impact of Clinical Protocols in the Management of Severe Sepsis: A Prospective Cohort Study
Phua, J., Ho, B. C. H., Tee, A. K. H., Chan, K., Johan, A., Loo, S., Soh, C. R., Chia, N. C. H., Tan, A. Y., Tham, H. M., et al. (2012) · Anaesthesia and Intensive Care · doi:10.1177/0310057x1204000413 · Cited by 16
Self-citation
Cited by
Rhee, C., Kadri, S. S., Dekker, J. P., Danner, R. L., Chen, H.-C., Fram, D., Zhang, F., Wang, R., Klompas, M., & Program, F. T. C. P. E. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.2899 · Cited by 397
Epidemiology and Immune Pathogenesis of Viral Sepsis
Lin, G.-L., McGinley, J. P., Drysdale, S. B., & Pollard, A. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02147 · Cited by 351
“Pneumonia is the most common clinical syndrome in patients with sepsis (21, 22, 28).”
BackgroundHow to use biomarkers of infection or sepsis at the bedside: guide to clinicians
Póvoa, P., Coelho, L., Dal-Pizzol, F., Ferrer, R., Huttner, A., Conway Morris, A., Nobre, V., Ramirez, P., Rouze, A., Salluh, J., et al. (2023) · Intensive Care Medicine · doi:10.1007/s00134-022-06956-y · Cited by 292
Antibiotic failure: Beyond antimicrobial resistance
de la Fuente-Nunez, C., Cesaro, A., & Hancock, R. E. W. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.101012 · Cited by 254
The Clinical Challenge of Sepsis Identification and Monitoring
Vincent, J.-L. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002022 · Cited by 259
“In the same study, 30% of cultures from infected patients were negative [14]; other studies have similarly reported that 30%–40% of ICU patients with sepsis have negative cultures [15,16].”
Result
Metadata
- Authors
- Phua, J., Ngerng, W. J., See, K. C., Tay, C. K., Kiong, T., Lim, H. F., Chew, M. Y., Yip, H. S., Tan, A., Khalizah, H. J., Capistrano, R., Lee, K. H., & Mukhopadhyay, A.
- Affiliations
- National University of Singapore (SG)
- Memorial University of Newfoundland (CA)
- Alexandra Hospital (SG)
- Raja Isteri Pengiran Anak Saleha Hospital (BN)
- Gleneagles Hospital (SG)
- Corresponding author
- Phua, Jason
- Venue
- Critical Care
- Published
- 2013-09-12
- Volume
- 17
- Issue
- 5
- Pages
- R202-R202
- ISSN
- 1364-8535 (ISSN-L)
- PMC
- PMC4057416
- OpenAlex
- W2019778131
- Cited by
- 382
- References
- 39
- Citations by year
- 2026: 15 · 2025: 25 · 2024: 33 · 2023: 40 · 2022: 42 · 2021: 57 · 2020: 43 · 2019: 44 · 2018: 15 · 2017: 20 · 2016: 26 · 2015: 6 · 2014: 13 · 2013: 1
- FWCI
- 11.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0/ (tdm)
- creativecommons.org/licenses/by/2.0/ (vor)
- Locations
- Critical Care (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- National University of Singapore (submittedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- Keywords
- culture-negative sepsis, culture-positive sepsis, severe sepsis, sepsis mortality, procalcitonin, APACHE II score, SOFA score, Gram-positive bacteria, Gram-negative bacteria, infection site, length of hospital stay, appropriate antibiotic therapy, ICU mortality
- MeSH terms
- Aged, Female, Gram-Negative Bacteria, Gram-Positive Bacteria, Humans, Intensive Care Units, Male, Middle Aged, Prospective Studies, Colony Count, Microbial, Cohort Studies, Treatment Outcome, Hospital Mortality, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.